Follow
Peter Verheesen
Peter Verheesen
argenx
Verified email at argenx.com
Title
Cited by
Cited by
Year
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
P Ulrichts, A Guglietta, T Dreier, T van Bragt, V Hanssens, E Hofman, ...
The Journal of Clinical Investigation 128 (10), 4372-4386, 2018
2022018
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly (A)-binding protein with a single-domain intracellular antibody
P Verheesen, A de Kluijver, S van Koningsbruggen, M de Brij, ...
Human molecular genetics 15 (1), 105-111, 2006
1052006
Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography
P Verheesen, MR Ten Haaft, N Lindner, CT Verrips, JJW De Haard
Biochimica et Biophysica Acta (BBA)-General Subjects 1624 (1-3), 21-28, 2003
942003
Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation
P Verheesen, A Roussis, HJ de Haard, AJ Groot, JC Stam, ...
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1764 (8), 1307-1319, 2006
852006
Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display
Y Huang, P Verheesen, A Roussis, W Frankhuizen, I Ginjaar, F Haldane, ...
European journal of human genetics 13 (6), 721-730, 2005
852005
Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction
E Regan-Klapisz, I Sorokina, J Voortman, P de Keizer, RC Roovers, ...
Journal of cell science 118 (19), 4437-4450, 2005
792005
Method and apparatus for receiving diversity signals for use in OFDM radio communication system
K Sato, M Namekata
US Patent 7,266,108, 2007
78*2007
Polypeptides that modulate the interaction between cells of the immune system
G Hermans, P Verheesen, E Dolk, HRJM Hoogenboom, MJS Saunders, ...
US Patent 8,907,065, 2014
57*2014
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial
M Goebeler, Z Bata‐Csörgő, C De Simone, B Didona, E Remenyik, ...
British Journal of Dermatology 186 (3), 429-439, 2022
562022
Polypeptides that modulate the interaction between cells of the immune system
G Hermans, P Verheesen, E Dolk, HRJM Hoogenboom, MJS Saunders, ...
US Patent 8,907,065, 2014
482014
Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha
AJ Groot, P Verheesen, EJ Westerlaken, EH Gort, P Van Der Groep, ...
Laboratory investigation 86 (4), 345-356, 2006
482006
Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression
R Klooster, MR Eman, Q le Duc, P Verheesen, CT Verrips, RC Roovers, ...
Journal of immunological methods 342 (1-2), 1-12, 2009
392009
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
HAP Revets, C Boutton, S Staelens, P Verheesen
US Patent App. 13/018,047, 2011
252011
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
HAP Revets, C Boutton, S Staelens, P Verheesen
US Patent App. 13/018,047, 2011
252011
Specific delivery of agrochemicals
E Jongedijk, P Verheesen
US Patent 8,598,081, 2013
202013
Selection by phage display of single domain antibodies specific to antigens in their native conformation
P Verheesen, T Laeremans
Single Domain Antibodies: Methods and Protocols, 81-104, 2012
182012
Amino acid sequences that modulate the interaction between cells of the immune system
G Hermans, P Verheesen, E Dolk, HRJM Hoogenboom, MJS Saunders, ...
US Patent App. 14/528,566, 2015
162015
FcRn antagonism leads to a decrease of desmoglein-specific B cells: secondary analysis of a phase 2 study of efgartigimod in pemphigus vulgaris and pemphigus foliaceus
M Maho-Vaillant, M Sips, ML Golinski, G Vidarsson, M Goebeler, ...
Frontiers in Immunology 13, 863095, 2022
152022
Glycine 236 in the lower hinge region of human IgG1 differentiates FcγR from complement effector function
M Brinkhaus, RGJ Douwes, AEH Bentlage, AR Temming, SW de Taeye, ...
The Journal of Immunology 205 (12), 3456-3467, 2020
152020
Amino acid sequences that modulate the interaction between cells of the immune system
G Hermans, P Verheesen, E Dolk, HRJM Hoogenboom, MJS Saunders, ...
US Patent 10,087,251, 2018
152018
The system can't perform the operation now. Try again later.
Articles 1–20